Titanium (Ti)-based materials have been used for dental and orthopedic implants because of their excellent biological compatibility, superior mechanical strength, and high corrosion resistance. The hypothesis of this present study was to manufacture the Zn-doped TiO2 layer possessing the biocompatibility and antibacterial ability on the surface of Ti specimens. TiO2, ZnO, and Ti(Zn)O-2 coatings were deposited on polished pure Ti substrates using a cathodic arc deposition system. Murine osteoblasts (MC3T3-E1) and human Staphylococcus aureus (S. aureus) were cultured onto the surface with different deposited coatings, respectively. The biocompatibility was examined by cell viability and osteogenic gene expression. The antibacterial ability was determined by SYTO9 nucleic acid staining. A porous Zn-doped TiO2 coating was successfully produced. The ZnO exhibited a fibrous structure with nanorods showing a hydrophobic feature (contact angle approximately 89 degrees). These material properties affected the following biological performance. The antibacterial testing found no apparent difference between the uncoated Ti plate and the TiO2 coating. However, significantly lower numbers of S. aureus were observed on ZnO and Ti(Zn)O-2 coatings compared to that on the uncoated Ti. The biocompatible testing exhibited that TiO2 and Ti(Zn)O-2 coatings enhanced greater cell viability and proliferation than the uncoated Ti plate and ZnO coating. The osteogenic gene expression of Dlx-5 and osterix also improved for the TiO2 and Ti(Zn)O-2 coatings. However, a significant inhibition of cell viability was found for the ZnO coating. These findings suggested that the composite Ti(Zn)O-2 coating with a lower content of Zn (7.6 +/- 1.3 at.%) not only improved antibacterial activity, but also maintained the biocompatibility to bone cells. (c) 2012 Elsevier B.V. All rights reserved.